Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MULTICENTER PHASE-II' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pangalis, GA; Dimopoulou, MN; Angelopoulou, MK; Tsekouras, C; Vassilakopoulos, TP; Vaiopoulos, G; Siakantaris, MP
      Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders - A review

      MEDICAL ONCOLOGY
    2. Smith, JA
      Alemtuzumab - A new option for refractory chronic lymphocytic leukemia?

      CANCER PRACTICE
    3. Heider, A; Niederle, N
      Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas

      ANTI-CANCER DRUGS
    4. Johnston, PG; Kaye, S
      Capecitabine: a novel agent for the treatment of solid tumors

      ANTI-CANCER DRUGS
    5. Green, MR
      The current status of docetaxel for advanced non-small cell lung cancer

      ANTI-CANCER DRUGS
    6. Natale, RB
      Gemcitabine and nonplatinum combinations in non-small-cell Lung cancer

      ONCOLOGY-NEW YORK
    7. Vose, JM
      Immunotherapy for non-Hodgkin's lymphoma

      ONCOLOGY-NEW YORK
    8. Pui, CH; Sailan, S; Relling, MV; Masera, G; Evans, WE
      International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000

      LEUKEMIA
    9. Dillman, RO
      Monoclonal antibodies in the treatment of malignancy: Basic concepts and recent developments

      CANCER INVESTIGATION
    10. Cunningham, D; Coleman, R
      New options for outpatient chemotherapy - the role of oral fluoropyrimidines

      CANCER TREATMENT REVIEWS
    11. White, CA; Weaver, RL; Grillo-Lopez, AJ
      Antibody-targeted immunotherapy for treatment of malignancy

      ANNUAL REVIEW OF MEDICINE
    12. Schnell, R; Hiddemann, W; Diehl, V; Engert, A
      Clinical use of monoclonal antibodies in malignant lymphomas

      INTERNIST
    13. Leis, JF; Maziarz, RT
      Specific immunotherapy for non-Hodgkin's lymphoma

      LABORATORY MEDICINE
    14. Maublant, J; Lumbroso, J; Cachin, F; Raoul, JL; Syrota, A; Vuillez, JP
      Nuclear medicine in oncology: New diagnostic and therapeutic methods

      BULLETIN DU CANCER
    15. Foran, JM; Norton, AJ; Micallef, INM; Taussig, DC; Amess, JAL; Rohatiner, AZS; Lister, TA
      Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis

      BRITISH JOURNAL OF HAEMATOLOGY
    16. Dearden, CE; Matutes, E; Cazin, B; Tjonnfjord, GE; Parreira, A; Nomdedeu, B; Leoni, P; Clark, FJ; Radia, D; Rassam, SMB; Roques, T; Ketterer, N; Brito-Babapulle, V; Dyer, MJS; Catovsky, D
      High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

      BLOOD
    17. Huhn, D; von Schilling, C; Wilhelm, M; Ho, AD; Hallek, M; Kuse, R; Knauf, W; Riedel, U; Hinke, A; Srock, S; Serke, S; Peschel, C; Emmerich, B
      Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

      BLOOD
    18. Steiner, T; Schubert, J
      Systemic treatment of renal-cell carcinoma: present status

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    19. Vose, JM
      MAb therapy: the use of anti-CD20 Abs - Therapeutic uses of MAbs directed against CD20

      CYTOTHERAPY
    20. Ladetto, M; Bergui, L; Ricca, I; Campana, S; Pileri, A; Tarella, C
      Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients

      MEDICAL ONCOLOGY
    21. Flynn, JM; Byrd, JC
      Campath-1H monoclonal antibody therapy

      CURRENT OPINION IN ONCOLOGY
    22. Terheyden, P; Becker, JC; Kampgen, E; Brocker, EB
      Sequential interferon-alpha 2b, interleukin-2 and fotemustine for patientswith metastatic melanoma

      MELANOMA RESEARCH
    23. Lin, YC; Chang, HK; Wang, CH; Chen, JS; Liaw, CC
      Single-agent docetaxel in metastatic breast cancer patients pre-treated with anthracyclines and paclitaxel: partial cross-resistance between paclitaxel and docetaxel

      ANTI-CANCER DRUGS
    24. Pitts, JM; Maloney, ME
      Therapeutic advances in melanoma

      DERMATOLOGIC CLINICS
    25. Owen, RG; Johnson, SA; Morgan, GJ
      Waldenstrom's macroglobulinaemia: Laboratory diagnosis and treatment

      HEMATOLOGICAL ONCOLOGY
    26. Byrd, JC; Waselenko, JK; Keating, M; Rai, K; Grever, MR
      Novel therapies for chronic lymphocytic leukemia in the 21st century

      SEMINARS IN ONCOLOGY
    27. Tsiodras, S; Samonis, G; Keating, MJ; Kontoyiannis, DP
      Infection and immunity in chronic lymphocytic leukemia

      MAYO CLINIC PROCEEDINGS
    28. Figgitt, DP; Wiseman, LR
      Docetaxel - An update of its use in advanced breast cancer

      DRUGS
    29. Feun, LG; Savaraj, M; Hurley, J; Marini, A; Lai, SH
      A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in thetreatment of patients with advanced malignant melanoma

      CANCER
    30. Cull, GM; Haynes, AP; Byrne, JL; Carter, GI; Miflin, G; Rebello, P; Hale, G; Waldmann, H; Russell, NH
      Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

      BRITISH JOURNAL OF HAEMATOLOGY
    31. Ulrich, J; Gademann, G; Gollnick, H
      Management of cerebral metastases from malignant melanoma: Results of a combined, simultaneous treatment with fotemustine and irradiation

      JOURNAL OF NEURO-ONCOLOGY
    32. Crown, J
      A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer

      SEMINARS IN ONCOLOGY
    33. RICHARD MA; GROB JJ; ZARROUR H; BASSERES N; BIZZARI JP; GERARD B; BONERANDI JJ
      COMBINED TREATMENT WITH DACARBAZINE, CISPLATIN, FOTEMUSTINE AND TAMOXIFEN IN METASTATIC MALIGNANT-MELANOMA

      Melanoma research
    34. Semb, KA; Aamdal, S; Bohmann, T; Lucas, C; Gerard, B
      Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma

      MELANOMA RESEARCH
    35. Seeber, A; Binder, M; Steiner, A; Wolff, K; Pehamberger, H
      Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

      EUROPEAN JOURNAL OF CANCER
    36. WEICHENTHAL M; MOHR P; STEPHAN U; ALTENHOFF J; KOWALZICK L; MARSEILLE A; SARKANY M; HOSSFELD DK; BREITBART EW
      FOTEMUSTINE AND INTERFERON-ALPHA-2B IN METASTATIC MALIGNANT-MELANOMA

      Journal of cancer research and clinical oncology
    37. KLEEBERG UR
      WISHFUL THINKING, UNICENTRIC EMPIRICISM AND THE EVERYDAY WORLD OF THEMEDICAL MELANOMOLOGIST

      Melanoma research
    38. KEILHOLZ U; GOEY SH; PUNT CJA; PROEBSTLE TM; SALZMANN R; SCHEIBENBOGEN C; SCHADENDORF D; LIENARD D; ENK A; DUMMER R; HANTICH B; GEUEKE AM; EGGERMONT AMM
      INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP

      Journal of clinical oncology
    39. BROCKER EB; BOHNDORF W; KAMPGEN E; TRCKA J; MESSER P; TILGEN W; ENGENHART K; FLENTJE M
      FOTEMUSTINE GIVEN SIMULTANEOUSLY WITH TOTAL BRAIN IRRADIATION IN MULTIPLE BRAIN METASTASES OF MALIGNANT-MELANOMA - REPORT AN A PILOT-STUDY

      Melanoma research
    40. FIORI E; LEONE G; GAZZANELLI S; GRAZIANO P; BACCARINI A; CANGEMI V; PIAT G
      INTRAOCULAR MALIGNANT-MELANOMA

      Journal of experimental & clinical cancer research
    41. BONERANDI JJ; HESSE S
      TREATMENT OF BRAIN METASTASES OF MALIGNANT-MELANOMA - VALUE OF FOTEMUSTINE

      Medicamentos de actualidad
    42. DEBRAUD F; BAJETTA E; ZAMPINO MG; NOLE F; LONGHI A; ZILEMBO N; COLLEONI M
      CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA (REVIEW)

      Oncology Reports
    43. KHAYAT D; GIROUX B; BERILLE J; COUR V; GERARD B; SARKANY M; BERTRAND P; BIZZARI JP
      FOTEMUSTINE IN THE TREATMENT OF BRAIN PRIMARY TUMORS AND METASTASES

      Cancer investigation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 22:58:05